Zacks Investment Research on MSN
Earnings Preview: Moderna (MRNA) Q3 Earnings Expected to Decline
The market expects Moderna (MRNA) to deliver a year-over-year decline in earnings on lower revenues when it reports results ...
Steven J. Hatfill has been ousted from his role at the federal health agency charged with preparing for disasters such as ...
The Covid-19 shot may have further-reaching benefits than previously thought, as mRNA vaccines appear to help increase the ...
The observation that mRNA vaccines can sensitize tumors to immunotherapy has researchers eager to test how mRNA’s ability to activate the immune system could be harnessed in oncology.
The study, published in the journal Nature, showed the jabs provided an immunity boost that helped extend survival for ...
The Covid-19 mRNA-based vaccines that saved 2.5 million lives globally in the pandemic could help spark the immune system to ...
A senior biosecurity adviser at the U.S. Department of Health and Human Services, who has made several critical statements ...
Small study looks only at a cardiac biomarker; findings are in line with reduced myocarditis risk in mRNA COVID vaccines ...
Researchers found that among cancer patients getting immunotherapy, those who got an mRNA Covid vaccine within 100 days ...
A new mRNA platform targets tumors with precision, limits side effects, and converts immune-silent cancers into responsive ...
Researchers found that COVID-19 mRNA vaccines significantly increased survival in lung and skin cancer patients undergoing immunotherapy. The vaccine appears to prime the immune system in a powerful, ...
Patients with advanced lung or skin cancer who received a COVID-19 mRNA vaccine within 100 days of starting immunotherapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results